<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/">
  <channel>
    <title>Choice International Ltd. (CHOICEIN) — Tipsheet</title>
    <link>https://tipsheet.markets/company/choicein/</link>
    <atom:link href="https://tipsheet.markets/company/choicein/feed.xml" rel="self" type="application/rss+xml" />
    <description>Every Tipsheet Editorial note covering Choice International Ltd. (CHOICEIN), newest first. Grounded in BSE/NSE primary-source filings.</description>
    <language>en-in</language>
    <lastBuildDate>Fri, 10 Jul 2026 05:38:02 GMT</lastBuildDate>
    <item>
      <title>NH Investment puts ₹900 cr into Choice&#39;s broking arm</title>
      <link>https://tipsheet.markets/choicein-nh-investment-puts-900-cr-into-choice-s-broking-arm-120416/</link>
      <guid isPermaLink="true">https://tipsheet.markets/choicein-nh-investment-puts-900-cr-into-choice-s-broking-arm-120416/</guid>
      <pubDate>Thu, 09 Jul 2026 13:33:03 GMT</pubDate>
      <description>South Korea&#39;s NH Investment &amp; Securities subscribes to 42,25,350 CCPs at ₹2,130 each in subsidiary CEBPL, which generates 51% of group revenue.</description>
      <content:encoded><![CDATA[<p><em>South Korea's NH Investment &amp; Securities subscribes to 42,25,350 CCPs at ₹2,130 each in subsidiary CEBPL, which generates 51% of group revenue.</em></p>
<h3>What’s new</h3><ul><li>Choice International's broking arm CEBPL signed definitive agreements with NH Investment &amp; Securities.</li><li>NH Investment will invest ₹900 crore via compulsorily convertible preference shares at ₹2,130 each.</li><li>Deal is subject to regulatory approvals; Choice International is a confirming party with indemnities.</li></ul>
<h3>Why it matters</h3><p>This is a large external validation from a top South Korean financial institution. CEBPL contributed 51% of group revenue in FY26; the capital will significantly strengthen its base for expansion. At about 5.25% of Choice's market cap, the infusion is material for the core broking business.</p>
<h3>What we’re watching</h3><ul><li>Regulatory approvals timeline and any conditions attached.</li><li>Deployment of funds—whether for organic growth, acquisitions, or technology.</li><li>Impact on CEBPL's market share and margins post-capital infusion.</li></ul>
<h3>The full read</h3><p>Choice International has landed a <strong>₹900 crore</strong> strategic investment from South Korea's NH Investment &amp; Securities in its broking subsidiary, Choice Equity Broking (CEBPL). The deal is structured via <strong>42,25,350 compulsorily convertible preference shares</strong> at <strong>₹2,130</strong> each. Hardly a routine capital raise. CEBPL is the group's engine and contributed <strong>51% of revenue</strong> and <strong>25% of net worth</strong> in FY26. For a mid-cap broking firm, this is a major vote of confidence from a foreign institutional heavyweight. The capital gives CEBPL firepower to expand its distribution and broking operations. At about <strong>5.25%</strong> of Choice's <strong>₹17,134 crore</strong> market cap, the infusion is material for the subsidiary. The open question is how Choice deploys the cash once regulatory approvals come through.</p>
<p>Primary source: <a href="https://www.bseindia.com/corporates/ann.html?scrip=531358&dur=A">BSE</a> · <a href="https://www.nseindia.com/companies-listing/corporate-filings-announcements?symbol=CHOICEIN">NSE</a></p>]]></content:encoded>
      <category>Other</category>
      <dc:creator>Tipsheet Editorial</dc:creator>
    </item>
  </channel>
</rss>